Recombinant Humanized Type III Collagen Enhances Fat Graft Retention by Promoting Angiogenesis and Adipocyte Viability in a Nude Mouse Model

Clicks: 1
ID: 319455
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #68 of 72 articles by views in Aesthetic surgery journal

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background Autologous fat grafting (AFG) is limited by variable long-term retention. Type III collagen (Col III) may support angiogenesis, adipocyte viability, and immunomodulation. Objectives We evaluated whether recombinant humanized type III collagen (rhCol III) improves fat graft survival in a concentration-dependent manner. Methods Human lipoaspirate was mixed 1:1 (v/v) with rhCol III at 0 (normal saline, NS), 2, 4, or 8 mg/mL and grafted subcutaneously to the dorsum of female BALB/c nude mice. At postoperative weeks 1, 2, 4, and 12, we assessed volume retention, histology (H&E), collagen deposition, adipocyte viability, vascularization, and expression of PPARG, CEBPA, VEGFA, and FGF2. RNA-seq at week 2 profiled rhCol III–associated transcriptional changes. In vitro, human ADSC proliferation, adhesion, migration, and adipogenesis were tested under rhCol III exposure. Results rhCol III reduced volume loss from week 2 onward, with maximal retention at 4 mg/mL. Histology showed superior structural integrity at 4 mg/mL. Collagen content increased dose-dependently (greatest at 8 mg/mL). Perilipin 1 and platelet endothelial cell adhesion molecule-1 (CD31) were elevated with rhCol III, with sustained increases at 4 mg/mL, paralleling upregulation of PPARG, CEBPA, VEGFA, and FGF2. In vitro, rhCol III enhanced ADSC proliferation, adhesion, migration, and adipogenesis, optimal at 4 mg/mL. RNA-seq indicated immune, adhesion, and extracellular matrix programs centered on PI3K–Akt and integrin/matrix–receptor signaling. Conclusions rhCol III enhances fat graft retention by promoting angiogenesis, adipocyte viability, and favorable immune remodeling, with an optimal concentration near 4 mg/mL. rhCol III shows promise as a biomaterial adjunct to improve and standardize AFG outcomes.
Reference Key
openalex_W7167071826 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Kaifang Hua, Xinyu Zhang, Jiyang Li, Zonglin Huang, Xiangyu Liu, Yuneng Wang, Chanyuan Jiang, Kaixuan Guo, Xuefeng Han
Journal Aesthetic surgery journal
Year 2026
DOI
10.1093/asj/sjag137
URL
https://doi.org/10.1093/asj/sjag137
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.